Sunday, October 25, 2026

WD 361: Brazil, JetBlue Bankruptcy, Mexican Airlines Merger

Brazil’s Lula victory leaves Nu and Inter’s thesis intact, while JetBlue heads toward bankruptcy and Mexican airlines pursue a merger.

JBLU $964MNU $73B

Ian’s Insider Corner Oct 25 11 clicks

Oct 25 AXP $211B

American Express: P&L Slowed, Consumer Didn’t

Librarian Capital's Research Library 3 clicks

Oct 25 SSTK $162M

💥Is Getty a Prepack in Name Only?💥

PETITION 4 clicks

From X

@stockgutter Oct 16

SG on X

in the spoon-bending world, today was more Amazing Randi than Uri Geller $BSP https://t.co/tYdep4viNo

@SowingAlphaSeed Oct 16 1 click

Farmer on X

Bought some $ABVX calls instead.

@SowingAlphaSeed Oct 16 3 clicks

Farmer on X

@Biohazard3737 $ZURA price action makes me think retail accounts getting margin called. Unless pods are yolo'ing into @A_May_MD pitches too.

@BlueDuckCap Oct 16 4 clicks

BDC on X

$XGN on sale here. $STIM also. IMHO. Not advice - as always.

@stockgutter Oct 16 2 clicks

SG on X

agree this stand the next few days is pivotal for $RTY $IWM https://t.co/mA1V6mYYrZ

@TidefallCapital Oct 16 5 clicks

Trevor Scott on X

$NVDA will just step in with some new capital to $CRWV. Not a good look having this bleed out..

@finphysnerd Oct 16 1 click

Myles on X

Apple not working, but the $CRWD trade is unwinding. Probably not going to stay in this one for too long but the thesis played out nicely. https://t.co/kI2lak0n6e

@valuedontlie Oct 16 5 clicks

Colin King on X

Anyone have access to BofA downgrade on $DCH? I'm long and this is a pretty steep cut lol https://t.co/6mhk6JRqA8

Philip Morris International: Ho-hum Hrmm?

Philip Morris posted 7% organic Q3 revenue growth and 10% operating-income growth as 9.1% cigarette pricing offset flat volumes, while IQOS…

PM $314B

Invariant Oct 25 12 clicks

Signet Jewelers (SIG): The Next Dillard’s?

Signet Jewelers cut its share count from 87 million to 38 million since 2012 as short interest reaches 15%, amid a hated diamond market.

SIG $4.5B

Cannibal Stocks Oct 25 14 clicks

Avalo Therapeutics: Contrarian 'Buy' Ahead Of Abdakibart's Phase 3

Avalo Therapeutics' Abdakibart enters a pivotal hidradenitis suppurativa trial after positive LOTUS data, with monthly dosing and…

AVTX $364M

Myriam Alvarez Oct 25 3 clicks

Tower Semiconductor Deep Dive

Tower Semiconductor’s low-loss photonics chips halve lasers in 1.6T optical modules, supporting a $680 million annualized photonics run…

TSEM $19B

CV's Substack Oct 24 9 clicks

Expert Call | AI Server OEM: 2026 xAI Orders, GB300 Price Hikes & B300 Margin Gains

Super Micro’s 2026 xAI rack orders, GB300 price increases and B300 mix frame its gross-margin outlook.

SMCI $23B

P Equity Research Oct 24 7 clicks

I went through all 142 companies in Value Line this morning. Here are the 6 that made it

Six Value Line small caps including Blackbaud, Marqeta, Ranger Energy and Definitive Healthcare trade on net cash, buybacks, low multiples…

BLKB $2.5BMQ $2B

Calvin Blissett Oct 24 76 clicks

Ares Capital: This 10%+ Yield Is An Undervalued Buy

Ares Capital’s 10%+ yield is supported by a $30.5 billion portfolio with over 70% floating-rate debt, though dividend coverage remains…

ARCC $13B

Jonathan Weber Oct 24 5 clicks

Margin Call

Petrobras’s Morpho-1 well revived hopes that Brazil’s Equatorial Margin can become a major new oil frontier after hydrocarbons were…

PBR $83B

Doomberg Oct 24 9 clicks

Applied Materials: Buy The Engineering Powerhouse Behind AI

Applied Materials targets AI-driven demand for advanced logic, DRAM and packaging, supported by services revenue and operating leverage…

AMAT $314B

Dhierin Bechai Oct 24 2 clicks

AI Narrative Switched, Debt Yields Spike | The Weekly Wrap

CoreWeave’s rising debt yields and fading confidence in AI data-center economics frame a weekly review of Meta, Tesla, SpaceX, Netflix,…

CRWV $30B

Steve Eisman Oct 23 28 clicks

JBFCY · long

Jollibee Foods CORP

Jollibee Foods trades at PHP 144, about 56% below its January 2019 high, framing a long thesis on the Philippine restaurant operator.

JBFCY $2.5B

Value Investors Club Jul 27 1 click

Our Views on CoreWeave

CoreWeave's financial statements point to a business model familiar to the authors after a closer review of the AI infrastructure company.

CRWV $30B

WHAT ARE WE DOING? “Contrarians At The Gate” Oct 23 12 clicks

DigitalOcean's AI Flywheel: Unleashing Massive Growth Potential For Bold Investors

DigitalOcean is pivoting toward affordable AI infrastructure and inference workloads, targeting share from AWS and Google Cloud amid…

DOCN $11B

Star Investments Oct 23 9 clicks

Bloom Energy (NYSE: BE) Q3 FY12/26 Earnings - Revenue Up 138% On The Datacenter Power Race

Bloom Energy’s Q3 FY26 revenue rose 138% to $1.24 billion as datacenter power orders lifted operating margin to 18%; capex drove $181…

BE $56B

Cestrian Capital Research Oct 23 9 clicks

Philip Morris: Taking the Fight to the U.S.

Philip Morris reported Q3 growth across heated tobacco, combustibles and e-vapor in Europe while gaining U.S. nicotine-pouch share.

PM $314B

Librarian Capital's Research Library Oct 23 3 clicks

Capital Wars

CoreWeave’s $35 billion to $39 billion 2026 spending plan relies on debt as unsecured yields reach 15%, making its GPU cloud expansion a…

CRWV $30B

Net Interest Oct 23 11 clicks

Spotify 3Q’26: Built for the Background

Spotify's third-quarter results met or exceeded guidance, with 306 million Premium subscribers and €672 million operating income, while…

SPOT $108B

MBI Deep Dives Oct 23 3 clicks

TSOH Weekly Roundup (10/23/2026)

TSOH Weekly Roundup covers Ally’s improving credit and capital returns, Pepsi’s weak beverage brands, and Match Group’s plan to revive…

ALLY $12BMTCH $11B

TSOH Investment Research Oct 23 4 clicks

Texas Instruments (NASDAQ: TXN) Stock Rating: HOLD After Q3 FY12/26 Earnings

Texas Instruments reported Q3 revenue of $6.06 billion, up 28%, with 47% operating margin and Q4 guidance above seasonal norms; Cestrian…

TXN $260B

Cestrian Capital Research Oct 23 6 clicks

Tempus AI: Moderna's New Cancer Vaccine Partner Is The Pick Of The AI Biotech Bunch

Tempus AI targets $1.6 billion of 2026 revenue through AI diagnostics, data licensing and cancer-testing partnerships, with Personalis…

TEM $13BMRNA $98B

Edmund Ingham Oct 23 4 clicks

Sunday, October 25, 2026

SG on X

Farmer on X

Farmer on X

BDC on X

SG on X

Trevor Scott on X

Myles on X

Colin King on X

Investor Letters

Publications we follow

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 62 of 255

X accounts we follow

Investor letters we follow

Sectors